. . . . . . . . . . . . "a(CHEBI:rosiglitazone) -> r(HGNC:PTEN)" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "1.4" . "The selective PPARgamma ligand rosiglitazone increased PTEN expression in AsPC-1 cells; concurrent treatment with GW9662, which inhibits PPARgamma activation, prevented the increase in PTEN protein levels." . . "Selventa" . . . . "2014-07-03T14:30:09.494+02:00"^^ . . .